COHERENT CORP.

# Signal Note: Driehaus Initiates $82.7M COHR Position Driehaus's entry into Coherent suggests conviction in the company's laser and photonics portfolio, which serves industrial, scientific, and medical applications—particularly ophthalmology and dermatology markets. The $82.7M position (447,945 shares) signals confidence in near-term execution or potential M&A activity, though COHR is primarily a diversified photonics player rather than a pure-play biotech with discrete clinical catalysts. Monitor for guidance updates or strategic partnerships in the medical device/aesthetics segments that could justify growth-stage capital redeployment.